Beyond the cough syrup: the complex, dissociative life of dextromethorphan

Beyond the cough syrup: the complex, dissociative life of dextromethorphan
Image: Intellect (generated)

In short: Commonly found in cold medicine, dextromethorphan is far more than a simple cough suppressant. Patented in 1949, this morphinan compound acts as a dissociative hallucinogen at high doses and has recently been approved as a rapid-acting antidepressant. Its pharmacological profile is a intricate web of receptors and metabolic pathways.

Dextromethorphan is the dextrorotatory enantiomer of levomethorphan, a morphinan compound. Unlike traditional opioids, it lacks significant affinity for mu-opioid receptors. Instead, it functions through a variety of mechanisms, including acting as a sigma-1 receptor agonist and a nonselective serotonin-norepinephrine reuptake inhibitor. At therapeutic doses, it acts centrally to elevate the cough threshold, but at higher levels, it and its active metabolite, dextrorphan, block NMDA receptors, producing effects comparable to dissociative anesthetics like ketamine.

The drug's metabolism is heavily dependent on the cytochrome P450 enzyme CYP2D6. Because genetic variations in this enzyme are common, individuals can be categorized as extensive, intermediate, or poor metabolizers. In poor metabolizers, the drug's effects and duration can be tripled. This metabolic pathway is so critical that some combination therapies, such as the treatment for pseudobulbar affect, include quinidine specifically to inhibit CYP2D6 and maintain higher circulating concentrations of the drug.

Despite its long history as an over-the-counter antitussive, dextromethorphan has faced scrutiny due to its potential for misuse. Research indicates that recreational use can lead to withdrawal symptoms and disturbances in mood and cognition. While FDA panels have debated restricting its availability, evidence that prescription-only status would curb abuse remains contested. Today, the drug continues to evolve, with new applications in psychiatry, such as its 2022 approval in combination with bupropion for major depressive disorder, highlighting its multifaceted role in modern medicine.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/health-dextromethorphan.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…